Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Dusza

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
JAMA Dermatology|April 12, 2018
Endocrine Therapy-Induced Alopecia in Patients With Breast CancerAzael Freites-Martinez, Jerry Shapiro, Donald Chan, et al.
Clinical and Experimental Dermatology|May 23, 2024
Artificial intelligence algorithms and three-dimensional volumetric rendering for basal cell carcinoma detection and tumour depth assessment in reflectance confocal microscopy-optical coherence tomography images: a pilot studyAlexander Pan, Nathalie de Carvalho, Luisa Silva, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 8, 2025
Platelet-Rich Plasma Treatment for Endocrine-Induced Alopecia and Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors: A Randomized, Controlled, Pilot StudyAnthony Rossi, Alexander Pan, Christian Menzer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 31, 2024
Cutaneous T-cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomesRobert Stuver, Stephen Dusza, Zachary D Epstein-Peterson, et al.
Research Square|May 10, 2023
Pruritus Related to Trastuzumab and Pertuzumab in HER2+ Breast Cancer PatientsStephanie Gu, Stephen Dusza, Elizabeth Quigley, et al.
Journal of the American Academy of Dermatology|November 28, 2025
No serum estradiol changes with 5-alpha reductase inhibitors for late alopecia in cancer survivors: A retrospective cohort studyMichael M Ong, Lavanya Mittal, Mario Lacouture, et al.
Breast Cancer Research and Treatment|October 13, 2023
Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patientsStephanie Gu, Stephen Dusza, Elizabeth Quigley, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 10, 2025
Skin Response to Mogamulizumab in Patients With Mycosis Fungoides and Sezary Syndrome: A Retrospective, Real World CohortRachel E Christensen, Robert Stuver, Stephen Dusza, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 12, 2025
Translational Potential of Fluorescent PARP1 Inhibitor as a Molecular Contrast Agent for Diagnosis of Basal Cell CarcinomaMiriam Ricanati, Ucalene Harris, Neil M Neumann, et al.
Journal of Cutaneous Pathology|September 29, 2020
Angulated small nests and cords: Key diagnostic histopathologic features of infiltrative basal cell carcinoma can be identified using integrated reflectance confocal microscopy-optical coherence tomographyMelissa Gill, Aditi Sahu, Christi Alessi-Fox, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
JAMA Dermatology|April 12, 2018
Endocrine Therapy-Induced Alopecia in Patients With Breast CancerAzael Freites-Martinez, Jerry Shapiro, Donald Chan, et al.
Clinical and Experimental Dermatology|May 23, 2024
Artificial intelligence algorithms and three-dimensional volumetric rendering for basal cell carcinoma detection and tumour depth assessment in reflectance confocal microscopy-optical coherence tomography images: a pilot studyAlexander Pan, Nathalie de Carvalho, Luisa Silva, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 8, 2025
Platelet-Rich Plasma Treatment for Endocrine-Induced Alopecia and Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors: A Randomized, Controlled, Pilot StudyAnthony Rossi, Alexander Pan, Christian Menzer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 31, 2024
Cutaneous T-cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomesRobert Stuver, Stephen Dusza, Zachary D Epstein-Peterson, et al.
Research Square|May 10, 2023
Pruritus Related to Trastuzumab and Pertuzumab in HER2+ Breast Cancer PatientsStephanie Gu, Stephen Dusza, Elizabeth Quigley, et al.
Journal of the American Academy of Dermatology|November 28, 2025
No serum estradiol changes with 5-alpha reductase inhibitors for late alopecia in cancer survivors: A retrospective cohort studyMichael M Ong, Lavanya Mittal, Mario Lacouture, et al.
Breast Cancer Research and Treatment|October 13, 2023
Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patientsStephanie Gu, Stephen Dusza, Elizabeth Quigley, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 10, 2025
Skin Response to Mogamulizumab in Patients With Mycosis Fungoides and Sezary Syndrome: A Retrospective, Real World CohortRachel E Christensen, Robert Stuver, Stephen Dusza, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 12, 2025
Translational Potential of Fluorescent PARP1 Inhibitor as a Molecular Contrast Agent for Diagnosis of Basal Cell CarcinomaMiriam Ricanati, Ucalene Harris, Neil M Neumann, et al.
Journal of Cutaneous Pathology|September 29, 2020
Angulated small nests and cords: Key diagnostic histopathologic features of infiltrative basal cell carcinoma can be identified using integrated reflectance confocal microscopy-optical coherence tomographyMelissa Gill, Aditi Sahu, Christi Alessi-Fox, et al.
Pageof 6